Showing results (261-270 of 334) with videos related to

Sort By:
Pageof 34
Marine Pollution Bulletin|July 10, 2026
Enhancing microplastic monitoring with ships of opportunity to determine baselines: Methodological design mattersAmy L Lusher, Svetlana Pakhomova, Cecilie Singdahl-Larsen, et al.
Heart Rhythm|January 18, 2011
Inside-out access: a new method of lead placement for patients with central venous occlusionsClaude S Elayi, Christopher L Allen, Steve Leung, et al.
Vox Sanguinis|January 1, 1990
Transmission of human immunodeficiency virus type 1 by dry-heated clotting factor concentrates. Transfusion Safety Study GroupS L Dietrich, J W Mosley, J M Lusher, et al.
Applied Spectroscopy|July 10, 2020
Sampling and Quality Assurance and Quality Control: A Guide for Scientists Investigating the Occurrence of Microplastics Across MatricesSusanne M Brander, Violet C Renick, Melissa M Foley, et al.
Pediatrics|August 1, 1991
Risk of human immunodeficiency virus type 1 infection among sexual and nonsexual household contacts of persons with congenital clotting disordersJ M Lusher, E A Operskalski, L M Aledort, et al.
BMC Health Services Research|August 19, 2025
Healthcare workers' perspectives on integrated oral and antenatal health care at public health facilities in southwestern nigeria: a qualitative studyLove Bukola Ayamolowo, Oluwabunmi Samuel Ibitoye, Ayodeji Omobolanle Esan, et al.
The Journal of Biological Chemistry|April 27, 2012
X-ray structures of progesterone receptor ligand binding domain in its agonist state reveal differing mechanisms for mixed profiles of 11β-substituted steroidsScott J Lusher, Hans C A Raaijmakers, Diep Vu-Pham, et al.
BMC Oral Health|June 12, 2024
Prevalence and associated risk factors for noma in Nigerian children: a systematic review and meta-analysisGeorge Uchenna Eleje, Emeka Emmanuel Okoh, Emeka Philip Igbodike, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 29, 2009
Clinical evaluation of moroctocog alfa (AF-CC), a new generation of B-domain deleted recombinant factor VIII (BDDrFVIII) for treatment of haemophilia A: demonstration of safety, efficacy, and pharmacokinetic equivalence to full-length recombinant factor VIIIM Recht, L Nemes, M Matysiak, et al.
BMC Research Notes|May 25, 2023
Differences in adoption of COVID-19 pandemic related preventive behaviour by viral load suppression status among people living with HIV during the first wave of the pandemicMorenike Oluwatoyin Folayan, Roberto Ariel Abeldaño Zuñiga, Nourhan M Aly, et al.
Pageof 34